Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions

Springer Seminars in Immunopathology
Yong-Guang Yang

Abstract

Xenotransplantation using pig organs provides a possible solution to the severe shortage of allogeneic organ donors, one of the major limiting factors in clinical transplantation. However, because of the greater antigenic differences that exist between different species than within a species, the immune response to xenografts is much more vigorous than to allografts. Thus, tolerance induction is essential to the success of clinical xenotransplantation. Tolerance induced by mixed hematopoietic chimerism across the MHC barrier is remarkably robust, but its ability to induce tolerance across highly disparate xenogeneic barriers remains poorly studied. None of the current available regimens of host conditioning, which permit hematopoietic stem cell engraftment and chimerism induction in allogeneic or closely related (concordant) xenogeneic combinations, has been demonstrated to be effective in establishing porcine hematopoietic chimerism in a discordant xenogeneic species. Unlike bone marrow transplantation within the same species, the innate immune system and the species specificity of cytokines and adhesion molecules essential to hematopoiesis pose formidable obstacles to the establishment of donor hematopoiesis across discordant...Continue Reading

References

Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K Ikuta, I L Weissman
Mar 6, 1992·Cell·P MombaertsV E Papaioannou
Jul 1, 1991·The Journal of Experimental Medicine·M OgawaS Nishikawa
Jul 1, 1990·Immunology Today·H G Ljunggren, K Kärre
Jan 1, 1981·Metabolic Bone Disease & Related Research·H Fleisch
Feb 10, 1983·Nature·G C BosmaM J Bosma
Oct 1, 1994·Veterinary Immunology and Immunopathology·D H Sachs
Sep 14, 1994·Journal of Immunological Methods·N Van Rooijen, A Sanders
Apr 1, 1996·The Journal of Experimental Medicine·M A GoodellR C Mulligan
Jan 1, 1996·Annual Review of Immunology·G AndersonE J Jenkinson
Apr 1, 1997·Surgery·T SablinskiD H Sachs
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·M BhatiaJ E Dick
Mar 24, 1998·Annual Review of Medicine·F H Bach
Apr 2, 1998·Current Opinion in Immunology·M MatsushitaT Fujita
May 23, 1998·The Journal of Experimental Medicine·Y G YangM Sykes
Jun 9, 1998·Stem Cells·D L GreinerL D Shultz
Aug 13, 1998·Transplantation·A N WarrensM Sykes
Dec 22, 1998·The Journal of Experimental Medicine·D MevorachK B Elkon
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·P J Quesenberry, P S Becker
Jun 4, 1999·Trends in Cell Biology·A D Whetton, G J Graham
Jun 8, 1999·Annual Review of Immunology·A Aderem, D M Underhill
Jun 8, 1999·Annual Review of Immunology·E SebzdaP S Ohashi
Jun 8, 1999·Annual Review of Immunology·E O Long

❮ Previous
Next ❯

Citations

Dec 16, 2004·Xenotransplantation·Reto M Baertschiger, Leo H Buhler
Jan 3, 2007·Experimental Hematology·Daniel S LaytonAndrew G D Bean
Aug 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Pietro ForteJörg D Seebach
Oct 15, 2008·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Aiqun WeiAshish D Diwan
May 27, 2009·Current Opinion in Organ Transplantation·Alain J PonceletPierre Gianello
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Benjamin G LilienfeldJörg D Seebach
Dec 17, 2004·Pediatric Diabetes·Joel F Habener

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.